肥胖的心血管与代谢异质性:临床挑战与管理启示
脂肪组织功能扰动、皮下脂肪扩张不足导致内脏与异位脂肪沉积、炎症/脂肪因子失调及胰岛素抵抗,与动脉粥样硬化性血脂异常、高胰岛素血症/糖耐量异常、高血压、动脉粥样硬化和不良心脏重构/心力衰竭相关。将脂肪分布评估纳入临床实践仍具挑战,生活方式、药物和手术干预可多学科管理超重/肥胖。
要点
- 体重指数单独定义肥胖高度异质,不能充分反映心血管代谢风险。
- 内脏与异位脂肪沉积是超越体重指数的心血管代谢风险重要贡献因素。
- 脂肪分布评估进入临床实践仍有挑战,影像学方法敏感性和特异性更优。
核心结论
- 肥胖是以体重指数定义时高度异质的状况,内脏与异位脂肪沉积是超越体重指数的心血管代谢风险重要贡献因素。
研究设计与样本
- 综述性文章,汇总近30年转化、流行病学和临床研究证据,未报告系统检索范围与样本量。
主要发现
- 皮下脂肪扩张不足面对膳食甘油三酯导致内脏与异位脂肪沉积、炎症/脂肪因子失调和胰岛素抵抗。
- 下半身脂肪储存优先可能作为代谢缓冲,保护其他组织免受脂质溢出和异位脂肪所致脂毒性。
- 内脏与异位脂肪与动脉粥样硬化性血脂异常、高胰岛素血症/糖耐量异常、高血压、动脉粥样硬化和不良心脏重构/心力衰竭临床综合征相关。
- 代谢健康肥胖表型和肥胖悖论使上述关系更为复杂。
临床怎么用
- 生活方式、药物和手术干预可多学科管理超重/肥胖,可能改善结局。
- 人体测量学肥胖指标易于实施,但影像学方法对特定脂肪库测量敏感性和特异性更优。
局限性
- 将脂肪分布评估纳入临床实践仍具挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prevalence of obesity has increased globally over the last 2 decades. Although the body mass index has been a convenient and simple index of obesity at the population level, studies have shown that obesity defined by body mass index alone is a remarkably heterogeneous condition with varying cardiovascular and metabolic manifestations across individuals. Adipose tissue is an exquisitely active metabolic organ engaged in cross-talk between various systems; perturbation of adipose tissue results in a pathological response to positive caloric balance in susceptible individuals that directly and indirectly contributes to cardiovascular and metabolic disease. Inadequate subcutaneous adipose tissue expansion in the face of dietary triglycerides leads to visceral and ectopic fat deposition, inflammatory/adipokine dysregulation, and insulin resistance. Conversely, preferential fat storage in the lower body depot may act as a metabolic buffer and protect other tissues from lipotoxicity caused by lipid overflow and ectopic fat. Translational, epidemiological, and clinical studies over the past 30 years have clearly demonstrated a strong link between visceral and ectopic fat and the development of a clinical syndrome characterized by atherogenic dyslipidemia, hyperinsulinemia/glucose intolerance, hypertension, atherosclerosis, and adverse cardiac remodeling/heart failure. This relationship is even more nuanced when clinical entities such as metabolically healthy obesity phenotype and the obesity paradox are considered. Although it is clear that the accumulation of visceral/ectopic fat is a major contributor to cardiovascular and metabolic risk above and beyond the body mass index, implementation of fat distribution assessment into clinical practice remains a challenge. Anthropometric indexes of obesity are easily implemented, but newer imaging-based methods offer improved sensitivity and specificity for measuring specific depots. Lifestyle, pharmacological, and surgical interventions allow a multidisciplinary approach to overweight/obesity that may improve outcomes and align with a public health message to combat the growing epidemic of obesity worldwide and to build healthier lives free of cardiovascular diseases.
引用
- Neeland IJ, Poirier P, Després JP, et al. Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management. Circulation. 2018. PMID: 29581366. doi:10.1161/CIRCULATIONAHA.117.029617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。